据了解,这种食品酶是田a href='//www.sqrdapp.com/news/tag_462.html' class='zdbq' title='非转基因相关食品资讯' target='_blank'>非转基因苍白氓a href='//www.sqrdapp.com/news/tag_2120.html' class='zdbq' title='芽孢杆菌相关食品资讯' target='_blank'>芽孢杆菌菌株AE-SAS生产的,旨在用于四种食品生产过程、/div>
经过评估,专家小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。部分原文报道如下:
The food enzyme 4--glucanotransferase (1,4--d-glucan:1,4--d-glucan 4--d-glycosyltransferase, EC 2.4.1.25) is produced with the non-genetically modified Aeribacillus pallidus strain AE-SAS by Amano Enzyme Inc. A safety e
valuation of this food enzyme was made previously, in which EFSA co
ncluded that this food enzyme did not give rise to safety co
ncerns when used in two food manufacturing processes. Subsequently, the applicant requested to extend its use to two additio
nal processes. In this assessment, EFSA updat
ed the safety e
valuation of this food enzyme for use in a total of four food manufacturing processes. As the food enzymeCtotal organic solids (TOS) is removed from the final foods in one food manufacturing process, the dietary exposure to the food enzymeCTOS was estimated o
nly for the remaining three processes. Dietary exposure was up to 0.040 mg TOS/kg body weight (bw) per day in European populations. When combined with the no observed adverse effect level reported in the previous opinion (900 mg TOS/kg bw per day, the highest dose tested), the Panel derived a margin of exposure of at least 22,500. ba
sed on the data provided for the previous e
valuation and the revised margin of exposure, the Panel co
ncluded that this food enzyme does not give rise to safety co
ncerns under the revised intended co
nditions of use.
本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@www.sqrdapp.com、/span>